Top

Published in:

01-12-2021 | COVID-19 | Review Article

Surgery for Cancer in the Wake of Second and Future Waves! Challenges and Opportunities in the Indian Context

Authors: Narendra Hulikal, Singaram Nagesh Kumar, Kodaganuru S. Gopinath

Published in: Indian Journal of Surgical Oncology | Special Issue 2/2021

Abstract

The pandemic situation created by newly discovered severe acute respiratory disease corona virus 2019 has thrown up many challenges to surgical fraternity across world. All surgeons particularly cancer surgeons are facing dilemmas not only in managing patients but also in appropriate personal as well as employee’s health protection as well. Since the pandemic is not expected to recede unless it affects a considerable proportion of population or up to 60% of population is vaccinated, we need to be aware of prevailing best practices. This is important in ensuring continuity of care for cancer patients as well as to limit the consequences of one getting infected with the COVID-19. This review article focuses on the current challenges and the ways to mitigate them.

Andrews MA, Areekal B, Rajesh KR et al (2020) First confirmed case of COVID-19 infection in India: a case report. Indian J Med Res 151:490–492CrossRef

Murhekar MV, Bhatnagar T, Thangaraj JWV et al (2021) SARS-CoV-2 sero-prevalence among general population and healthcare workers in India, December 2020 - January 2021. Int J Infect Dis. https://doi.org/10.1016/j.ijid.2021.05CrossRefPubMedPubMedCentral

Liang W, Guan W, Chen R et al (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21:335–337CrossRef

Fillmore NR, La J, Szalat RE et al (2020) Prevalence and outcome of COVID-19 infection in cancer patients: a national veterans affairs study. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djaa159CrossRefPubMedCentral

Curigliano G, Banerjee S, Cervantes A et al (2020) Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus. Ann Oncol 31:1320–1335CrossRef

Hanson KE, Caliendo AM, Arias CA et al (2020) Infectious Diseases Society of America Guidelines on the Diagnosis of Coronavirus Disease 2019. Clin Infect Dis 16:760. https://doi.org/10.1093/cid/ciaa760CrossRef

Patell R, Bogue T, Bindal P et al (2020) Incidence of thrombosis and hemorrhage in hospitalized cancer patients with Covid-19. J Thromb Haemost 18:23499–32357CrossRef

Ueda M, Martins R, Hendrie PC et al (2020) Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal. J Natl Compr Canc Netw 20:1–4. https://doi.org/10.6004/jnccn.2020.7560CrossRef

Curtis JR, Kross EK, Stapleton RD (2020) The importance of addressing advance care planning and decisions about do-not-resuscitate orders during novel coronavirus 2019 (COVID-19). JAMA 323:1771–1772PubMed

10.

Perni S, Milligan MG, Saraf A et al (2020) Treating the SARS-CoV-2–positive patient with cancer: a proposal for a pragmatic and transparent ethical process. Cancer 126:3896–3899CrossRef

11.

Yekedüz E, Utkan G, Ürün Y (2020) A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19. Eur J Cancer 141:92–104CrossRef

12.

El-Boghdadly K, Cook TM, Goodacre T et al (2021) SARS-CoV-2 infection, COVID-19 and timing of elective surgery. Anaesthesia 76:748–758CrossRef

13.

Avanzato VA, Matson MJ, Seifert SN et al (2020) Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell 183:1901–1912CrossRef

14.

Desai S, Gupta A (2020) Indian J Surg Oncol 11:171–174CrossRef

15.

Cinar P, Kubal T, Freifeld A et al (2020) Safety at the time of the COVID-19 pandemic: how to keep our oncology patients and healthcare workers safe. J Natl Compr Canc Netw 18:504–558CrossRef

16.

https://www.mohfw.gov.in/pdf/Telemedicine.pdf. Accessed on 22 May 2021

17.

Becker AS, Perez-Johnston R, Chikarmane SA et al (2021) Multidisciplinary recommendations regarding post-vaccine adenopathy and radiologic imaging Radiology Scientific Expert Panel. Radiology 24:210436. https://doi.org/10.1148/radiol.2021210436CrossRef

18.

Hanna TP, King WD, Thibodeau S et al (2020) Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ 371:m4087. https://doi.org/10.1136/bmj.m4087CrossRefPubMed

19.

Hartman HE, Sun Y, Devasia TP et al (2020) Integrated survival estimates for cancer treatment delay among adults with cancer during the COVID-19 pandemic. JAMA Oncol 6:1881–1889CrossRef

20.

COVID19 Subcommittee of the O.R. Executive Committee at Memorial Sloan Kettering (2020) Cancer Surgery and COVID19. Ann Surg Oncol 27:1713–1716. https://doi.org/10.1245/s10434-020-08462-1CrossRef

21.

Thompson CK, Lee MK, Baker JL et al (2020) Taking a second look at neoadjuvant endocrine therapy for the treatment of early stage estrogen receptor positive breast cancer during the COVID-19 outbreak. Ann Surg 272:e96–e97. https://doi.org/10.1097/SLA.000000000000402CrossRefPubMed

22.

COVIDSurg Collaborative (2020) Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet 396:27–38

23.

Cohn JA, Ghiraldi EM et al (2021) A critical appraisal of the American College of Surgeons Medically Necessary, Time Sensitive Procedures (MeNTS) scoring system, urology consensus recommendations and individual surgeon case prioritization for resumption of elective urological surgery during the COVID-19 pandemic. J urol 205:241–247CrossRef

24.

Kutikov A, Weinberg DS, Edelman MJ et al (2020) A war on two fronts: cancer care in the time of COVID-19. Ann Intern Med 172:756–758CrossRef

25.

Hanna TP, Evans GA, Booth CM (2020) Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol 17:268–270CrossRef

26.

Hwang ES, Balch CM, Balch GC et al (2020) Surgical oncologists and the COVID-19 pandemic: guiding cancer patients effectively through turbulence and change. Ann Surg Oncol 27:2600–2613CrossRef

27.

Berlin A, Lovas M, Truong T et al (2021) Implementation and outcomes of virtual care across a tertiary cancer centre during COVID-19. JAMA Oncol 7:597–602CrossRef

28.

Emanuel EJ, Persad G, Upshur R et al (2020) Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med 382:2049–2055CrossRef

29.

https://www.natboard.edu.in/viewNotice.php?NBE=T3NNNVRoc09xUW5kTHhLMXpJZFFRdz09. Accessed on 22 May 2021.

30.

van Doesum J, Chinea A, Pagliaro M et al (2020) Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands. Leukemia 34:2536–2538CrossRef

31.

Araujo DV, Watson GA, Siu LL (2021) The day after COVID-19—time to rethink oncology clinical research. JAMA Oncol 7:23–24. https://doi.org/10.1001/jamaoncol.2020.4240

Title: Surgery for Cancer in the Wake of Second and Future Waves! Challenges and Opportunities in the Indian Context
Authors: Narendra Hulikal
Singaram Nagesh Kumar
Kodaganuru S. Gopinath
Publication date: 01-12-2021
Publisher: Springer India
Keyword: COVID-19
Published in: Indian Journal of Surgical Oncology / Issue Special Issue 2/2021
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-021-01392-8

At a glance: The STEP trials

Springer Medicine

Surgery for Cancer in the Wake of Second and Future Waves! Challenges and Opportunities in the Indian Context

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 2/2021

A Rare Case Presentation of Retroperitoneal Teratoma in Adults

Analysis of Early Impact of COVID-19 on Presentation and Management of Oral Cancers – an Experience from a Tertiary Care Hospital in South India

Elective Surgical Experience During COVID Pandemic at a Tertiary Cancer Care Centre in India: A Retrospective Analysis

Multicentric Giant Cell Tumor of Bone: Metachronous Presentation—a Case Report

Upper Tract Urothelial Carcinoma with Intra-renal Haemorrhage

Multidisciplinary Perioperative Management of Hyperthermic-Isolated Limb Perfusion for Malignant Melanoma: A Case Report